Asceneuron
Business Services · Switzerland · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Epfl Innovation Park Bâtiment B, Lausann...Phone Number
+41 216938242Website
www.asceneuron.comRevenue
<$5 MillionIndustry
About Asceneuron
Is Asceneuron your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Asceneuron has new funding data
Check out if Asceneuron is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Asceneuron launches new products
Check if Asceneuron has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Asceneuron recently announced quarterly report
Asceneuron, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Asceneuron
Click to see if Asceneuron had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Asceneuron
Find 3 more new buyers
Company Profile Activity
Activity Insights
Asceneuron is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Asceneuron is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Asceneuron.
Asceneuron financials insights
Gather financial insights about Asceneuron, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$30.6M
Series C
$100M
Asceneuron Tech Stack
A closer look at the technologies used by Asceneuron
Most Recent Scoops
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Asceneuron
Asceneuron, founded in 2012 and headquartered in Lausanne, Switzerland, discovers and develops innovative small molecules to halt and prevent key molecular events in the brain that lead to neurodegeneration. Asceneuron strives to address high unmet medical needs in neurodegenerative diseases such as orphan tauopathies, Alzheimer’s, and Parkinson’s... Read More